title: Advances in antiretroviral therapy.
abstract: The 18th Conference on Retroviruses and Opportunistic Infections maintained its tradition of being the preeminent forum for detailing the state-of the-art in antiretroviral therapy. There were important presentations on investigational antiretroviral drugs, clinical trials in treatment-experienced patients, and new antiretroviral strategies. Relevant data on resistance to antiretroviral drugs and pharmacokinetic interactions were discussed. There were extensive presentations on antiretroviral therapy in resource-limited settings, including large-scale clinical trials, scale-up of antiretroviral therapy, adherence, retention in care, and treatment outcomes for children and adults. Prevention of mother-to-child transmission continued to be an important part of the conference.
authors.affiliation: Division of Infectious Diseases, University of Texas, San Antonio, TX, USA.
authors.forename: Barbara
authors.initials: B
authors.lastname: Taylor
authors.forename: Susan
authors.initials: S
authors.lastname: Olender
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Wilkin
authors.forename: Scott M
authors.initials: SM
authors.lastname: Hammer
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D044966:Anti-Retroviral Agents / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D002626:Chemistry, Pharmaceutical / Q000639:trends; D002986:Clinical Trials as Topic; D003906:Developing Countries; D024882:Drug Resistance, Viral; D006801:Humans; D055118:Medication Adherence; D016896:Treatment Outcome
chemical_list: D044966:Anti-Retroviral Agents